Stock POINT CAPITAL INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. Point Capital Inc Other OTC

Equities

US73052R1041

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Laidlaw Initiates Silo Pharma With Buy Rating, Price Target is $10
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SILO Stock
  4. Stock
  5. News Point Capital Inc
  6. Analyst Reco.